{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T21:45:11Z","timestamp":1725659111506},"reference-count":6,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Hematology and Oncology Department of the National Institute of Medical Sciences and Nutrition Salvador Zubiran"}],"content-domain":{"domain":["lrjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1016\/j.leukres.2014.03.015","type":"journal-article","created":{"date-parts":[[2014,3,25]],"date-time":"2014-03-25T17:46:15Z","timestamp":1395769575000},"page":"660-661","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["VEGF in chronic myeloid leukemia treated with interferon and imatinib"],"prefix":"10.1016","volume":"38","author":[{"given":"Alvaro","family":"Aguayo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2014.03.015_bib0005","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1182\/blood.V69.5.1280.1280","article-title":"Clinical investigation of human alfa interferon in chronic myelogenous leukemia","volume":"69","author":"Talpaz","year":"1987","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2014.03.015_bib0010","doi-asserted-by":"crossref","first-page":"3069","DOI":"10.1182\/blood.V87.8.3069.bloodjournal8783069","article-title":"Treatment of myelogenous leukemia: current status and investigational options","volume":"87","author":"Kantarjian","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2014.03.015_bib0015","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/leu.2012.313","article-title":"Re-emerge of interferon-\u03b1 in the treatment of chronic myeloid leukemia","volume":"27","author":"Talpaz","year":"2013","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2014.03.015_bib0020","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1182\/blood.V96.6.2240","article-title":"Angiogenesis in acute and chornic leukemias and myelodysplastic syndromes","volume":"96","author":"Aguayo","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2014.03.015_bib0025","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.leukres.2014.01.010","article-title":"Interferon decreases VEGF levels in patients with chronic myeloid leukemia treated with imatinib","volume":"38","author":"Legros","year":"2014","journal-title":"Leuk Res"},{"key":"10.1016\/j.leukres.2014.03.015_bib0030","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.leukres.2003.11.017","article-title":"Effect of antisense VEGF cDNA transfection on the growth of chronic myeloid leukemia K562 cells in vitro and in nude mice","volume":"28","author":"Ruan","year":"2004","journal-title":"Leuk Res"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212614000770?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212614000770?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,16]],"date-time":"2020-08-16T20:25:37Z","timestamp":1597609537000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212614000770"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":6,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["S0145212614000770"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2014.03.015","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2014,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"VEGF in chronic myeloid leukemia treated with interferon and imatinib","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2014.03.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2014.01.010","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}